e-learning
resources
Virtual 2021
06.09.2021
Comorbidities in airway obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical characterization of T2 low phenotype
V. Carriero (Orbassano, Italy), A. Sprio (Orbassano, Italy), A. Baroso (Orbassano, Italy), G. Ciprandi (Genova, Italy), E. Riccardi (Orbassano, Italy), F. Bertolini (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy)
Source:
Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Session:
Comorbidities in airway obstructive diseases
Session type:
E-poster
Number:
2219
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Carriero (Orbassano, Italy), A. Sprio (Orbassano, Italy), A. Baroso (Orbassano, Italy), G. Ciprandi (Genova, Italy), E. Riccardi (Orbassano, Italy), F. Bertolini (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy). Clinical characterization of T2 low phenotype. 2219
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Static lung volumes and spirometry measurements
Related content which might interest you:
BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Clinical and functional characteristics of the natural course of COPD
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021
Clinical and functional assessment according to the exacerbating phenotype in COPD
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
Adult asthma phenotypes identified by a cluster analysis on clinical and biological characteristics
Source: International Congress 2018 – Asthma in children and adults: long-term aspects
Year: 2018
Clinical and transcriptomic profiles of severe asthmatics with high or low expression of the glucocorticoid receptor and importin-7.
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
Influence of early growth on childhood lung function assessed by magnetic resolution imaging and spirometry. The Generation R Study.
Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology
Year: 2017
Initial clinical phenotype of COPD: Correlation with the natuaral history of the disease
Source: Annual Congress 2011 - COPD management
Year: 2011
Cluster analysis identifies distinct clinical phenotypes with poor treatment responsiveness in asthma.
Source: International Congress 2018 – Asthma: clinical screening tools
Year: 2018
Limitations of current clinical diagnosis: phenotype versus endotype
Source: International Congress 2014 – PG12 The omics revolution: the future of personalised medicine
Year: 2014
Novel method of expressing serum biomarkers profiling in COPD patients: The heatmap-clinical pattern profile
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
LSC 2010 Abstract: Influence of mutations and COPD clinical features on
SERPINA1
phenotypic expression
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
Genes expression and histological phenotype
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004
Importance of clinical, radiological and functional methods of investigation for diagnosis and assessment of the efficiency of treatment of Langerhans' cell histiocytosis
Source: Eur Respir J 2001; 18: Suppl. 33, 383s
Year: 2001
Clinical presentation in CF patients with large deletions
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
Comparative biochemical and cytological activity markers according to the radiographic pattern in patients with newly diagnosed sarcoidosis
Source: Annual Congress 2007 - Sarcoidosis: various aspects
Year: 2007
Clinical phenotyping of COPD patients: a simple tool with prognosis value
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
Combined assessment of regional lung function and morphology using a contrast enhanced Dual-Energy CT protocol: Prospective value of functional imaging biomarkers in longitudinal analysis of patients with Interstitial Lung Disease
Source: Virtual Congress 2020 – What is new in interstitial lung diseases of known origin?
Year: 2020
Distribution and determinants of restrictive functional pattern
Source: Annual Congress 2011 - Lung and airway function
Year: 2011
Simultaneous analysis of clinical markers for predicting increased lung function fluctability in stable asthma
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012
Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept